Drugs & Targets FDA Approves Ninlaro and Darzalex For the Treatment of Multiple Myeloma November 30, 2015Vol.38 No.11
Drugs & Targets Eli Lilly and Merck extend phase III Alimta-Keytruda study collaboration November 20, 2015Vol.41 No.43
Drugs & Targets Ninlaro first protesome inhibitor approved in multiple myeloma November 20, 2015Vol.41 No.43
Drugs & Targets Approvals Granted to Darzalex and Ninlaro in Multiple Myeloma November 20, 2015Vol.41 No.43
Drugs & Targets Tagrisso Granted Accelerated Approval in Non-Small Cell Lung Cancer November 13, 2015Vol.41 No.42
Drugs & TargetsFree FDA grants Breakthrough Therapy designation to pexidartinib November 06, 2015Vol.41 No.41
Drugs & TargetsFree TCGA Researchers Identify Seven Subtypes of Prostate Cancer and Drivers of Papillary Renal Cell Carcinoma November 06, 2015Vol.41 No.41
Drugs & Targets FDA Approves Imlygic as First Oncolytic Viral Therapy in the U.S., for Melanoma November 03, 2015Vol.38 No.10
